x
ServiziMenu principaleHome
You are here: Home > Projects > Improving Care of Metastatic Breast Cancer (MBC) Patients in Europe
Print

Improving Care of Metastatic Breast Cancer (MBC) Patients in Europe

Pfizer will partner with SPCC on an RFP-driven grant-making initiative to provide funding to European healthcare institutions and organizations interested in implementing specific guideline recommendations for improving the quality of breast cancer care in their hospitals, health systems, or cancer care centres.

Goal of the project “Improving care of metastatic breast cancer (MBC) patients in Europe” is to provide funding to European healthcare institutions and organizations interested in implementing specific guideline recommendations or to improve the quality of breast cancer care in their hospitals, health systems or cancer care centres or networks by means of grants based on Requests for Proposals (RFP), through a Pfizer platform. This will be implemented through a two-stage review process.

A Request for Proposals (RFP) will have to be developed and will describe the types of projects eligible for consideration. Project proposals should include elements such as initial assessment of current practice, strategies for implementing improvements into routine care including potentially embedding as a pathway or algorithm in the patient file or Electronic Medical Record (EMR) system, capturing clinical outcomes in the patient file or EMR system and a plan for educating the healthcare professional staff on the updated care plans, and a plan for measuring success such as effectiveness against quality metrics.

This SPCC-led expert panel will review proposals and select the highest quality projects.

 

Expert panel reviewers

Matti S. Aapro, Clinique de Genolier - Sharing Progress in Cancer Care (SPCC), Genolier/Bellinzona

Giuseppe Curigliano, European Institute of Oncology, Milan

Lucia Del Mastro, IRCCS Ospedale Policlinico San Martino–University of Genoa

Pascale Dielenseger, Gustave Roussy, Villejuif

Alex Eniu, Riviera-Chablais Vaud-Valais, Rennaz

Joseph Gligorov, University Cancer Institute APHP.6, Sorbonne University, Paris

Nadia Harbeck, University of Munich

Pietro Presti, Sharing Progress in Cancer Care (SPCC), Turin/Bellinzona

Elzbieta Senkus, Medical University of Gdansk

Rosanna Tarricone, Bocconi University, Milan

 

Focus on

  • Metastatic and advanced breast cancer patients
  • Differences between current practice and guideline-based standard of care
  • Challenges & opportunities related to the experience/expertise of health care professionals, the resources/strengths/weaknesses of their health systems, or other factors related to the external environment or patient population.

 

Areas of interest

  1. Delivering the optimal treatment approach for patients with MBC by selecting optimal therapeutic strategies, as well as by appropriately applying and understanding genetic testing.
  2. Optimal treatment strategies for patients with MBC based on patient and tumor characteristics.
  3. Therapy management/Patient adherence
  4. Patient education, treatment goals, and engagement in decision making
  5. Primary care (GYN, Surgeons) as point of treatment for MBC patients
  6. Patient reported outcomes

 

Targeted groups of patients

  • elderly patients
  • patients living far from reference cancer centres/hospitals
  • patients with multiple co-morbidity